The Amylase (Serum) test is a blood test that measures the amount of amylase in your bloodstream. Amylase is a digestive enzyme that helps break down carbohydrates (starches) into sugars. It is produced mainly by the pancreas and the salivary glands (glands in the mouth).

When the pancreas becomes inflamed or injured, amylase can leak into the blood, causing the serum amylase level to rise. Because of this, the test is commonly used to help evaluate symptoms that may be related to pancreatitis or other pancreatic disorders.

In plain language, results are usually interpreted like this:

• High amylase: Often suggests pancreatic inflammation or blockage, especially when paired with typical symptoms (such as severe upper abdominal pain). However, amylase can also rise due to non-pancreatic causes such as salivary gland problems, intestinal conditions, gallbladder disease, kidney problems (reduced clearance), or certain medications. A single elevated value does not always mean pancreatitis, so your clinician may compare it with symptoms, other labs (especially lipase), and imaging when needed.

• Normal amylase: Makes acute pancreatitis less likely, but it does not completely rule it out. Timing matters—amylase may rise and fall over days, and some people with pancreatitis can have normal levels.

• Low amylase: Is less common and is usually not an emergency finding. In some cases, it may be seen with long-term pancreatic damage (reduced enzyme production) or certain metabolic conditions. Interpretation depends on your overall clinical picture.

Your healthcare provider may order a serum amylase test when you have symptoms or risk factors that could involve the pancreas or upper abdominal organs. It may be used to help diagnose a new problem, monitor recovery, or track ongoing pancreatic disease.

Common reasons include:

• Symptoms of acute pancreatitis or pancreatic irritation: sudden, severe pain in the upper abdomen (often radiating to the back), nausea/vomiting, abdominal tenderness, fever, or a swollen abdomen.

• Evaluation of abdominal pain: especially when the pain is persistent, severe, or accompanied by vomiting, or when your clinician needs to distinguish pancreas-related pain from other causes (gallbladder, intestines, etc.).

• Monitoring known pancreatitis: to follow trends over time in combination with symptoms and other tests (lipase, liver enzymes, imaging).

• Risk factors that raise concern for pancreatitis: gallstones, heavy alcohol use, very high triglycerides, certain medications (your clinician will review yours), recent abdominal injury/procedure, or a history of pancreatitis.

• Possible salivary gland conditions: because salivary glands also produce amylase, the test may be considered when there is facial swelling or suspected salivary gland inflammation.

• Acute pancreatitis
• Chronic pancreatitis (may be elevated during flares; can be normal/low in advanced disease)
• Pancreatic duct obstruction (for example, due to a stone or stricture)
• Gallstone-related disease that can trigger pancreatitis (cholelithiasis/choledocholithiasis)
• Pancreatic pseudocyst (a fluid collection after pancreatitis)
• Pancreatic cancer (can be associated in some cases, but amylase is not a screening test)
• Salivary gland inflammation (parotitis, including mumps)
• Kidney disease (reduced clearance can raise serum amylase)
• Intestinal obstruction or intestinal inflammation/ischemia (can cause elevations)

• Evaluating and monitoring pancreas health when symptoms suggest pancreatitis
• Supporting digestive health assessment during episodes of severe abdominal pain, nausea, or vomiting
• Tracking recovery after acute pancreatitis alongside other labs (especially lipase) and clinical symptoms
• Assessing potential complications related to gallstones or bile duct blockage that may involve the pancreas
• Reviewing the impact of medications or alcohol when there is concern for pancreatic irritation
• Adding context in broader evaluations where kidney function or salivary gland disease may affect amylase levels